Skip to content

The effect of exercise on elderly diabetic

Investigating the effect of resistance training with elastic bands on cardiometabolic and functional factors of elderly diabetic women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241008063290N1
Enrollment
30
Registered
2024-11-18
Start date
2024-12-19
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: 12 weeks of resistance training with elastic bands (changing the color of the bands will be considered in order to increase the intensity of the training, which wil

Sponsors

Iran National Science Foundation
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: Woman Elderly Having general health Being in the age range of 65-80 years Suffering from type 2 diabetes with a history of more than Two years Fasting glucose more than 126 mg/dL 2-hour glucose more than 200 mg/dL HbA1c level more than 6.5%

Exclusion criteria

Exclusion criteria: Insufficient physical ability Insufficient awareness Having psychological problems Having acute cardiovascular diseases Smoking and alcohol use Lack of mobility Using walkers and wheelchairs Having a special diet Weight instability in the last 3 months

Design outcomes

Primary

MeasureTime frame
Galectin-3. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Adiponectin. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Physical fitness factor (strength). Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Functional tests.;Growth differentiation factor-15 (GDF15). Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Triglycerides. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Total cholesterol. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Low density lipoprotein. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;High density lipoprotein. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Tumour necrosis factor alpha. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;C-reactive protein. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Insulin. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Through ELISA method in blood serum samples.;Glucose. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Glucose oxidase method.;Insulin resistance. Timepoint: At baseline and 48 hours after last session of training. Method of measurement: Mathematical formula.;Glycosylated hemoglobin. Ti

Secondary

MeasureTime frame
Body composition. Timepoint: At baseline and 48 hours after the last training session. Method of measurement: Body composition device.;Blood plessure. Timepoint: At baseline and 48 hours after the last training session. Method of measurement: Germany Bearer digital blood pressure device.;Sleep quality. Timepoint: At baseline and 48 hours after the last training session. Method of measurement: Pittsburg Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthamid rajabi

Kharazmi University

UMZ.kheradmand@gmail.com0098 21 88329220-3

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026